According to a report in the journal PharmacoEconomics published on Tuesday, long-term use of beta interferon may slow down the onset of the disease and consequent degree of patient disability and associated care costs. Switzerland's Serono SA , has been widely endorsed by Britain's drug industry and sufferers. MS is incurable and causes the body's immune system to destroy a sheath protecting nerve cells in the brain and spinal cord, causing paralysis, pain and tremors.
Users say beta interferon reduces the frequency and severity of the painful bouts.